The University of Chicago Header Logo

Rita Nanda

Concepts (321)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Rita Nanda's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Rita Nanda has written about over time.
Receptors, Estrogen, 13 publications between 2006 and 2025, average publication date March 2017. Receptors, Progesterone, 9 publications between 2009 and 2025, average publication date November 2017. Antibodies, Monoclonal, Humanized, 15 publications between 2007 and 2024, average publication date December 2017. Breast Neoplasms, 69 publications between 2005 and 2025, average publication date July 2018. Female, 94 publications between 2005 and 2025, average publication date November 2018. Antineoplastic Combined Chemotherapy Protocols, 38 publications between 2012 and 2024, average publication date March 2019. Trastuzumab, 17 publications between 2007 and 2024, average publication date September 2019. Paclitaxel, 13 publications between 2014 and 2024, average publication date September 2019. Receptor, ErbB-2, 31 publications between 2006 and 2025, average publication date October 2019. Biomarkers, Tumor, 24 publications between 2009 and 2025, average publication date January 2020. Neoplasm Staging, 21 publications between 2007 and 2024, average publication date February 2020. Programmed Cell Death 1 Receptor, 4 publications between 2018 and 2024, average publication date June 2020. Neoadjuvant Therapy, 34 publications between 2012 and 2025, average publication date November 2020. Triple Negative Breast Neoplasms, 28 publications between 2014 and 2025, average publication date January 2021. B7-H1 Antigen, 7 publications between 2018 and 2024, average publication date February 2021. Immunotherapy, 8 publications between 2017 and 2025, average publication date December 2021. Camptothecin, 4 publications between 2014 and 2024, average publication date February 2022. Complementary Therapies, 2 publications between 2023 and 2024, average publication date September 2023. Immunoconjugates, 4 publications between 2022 and 2024, average publication date March 2024.

To see the data from this visualization as text, click here.
Nanda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (321)
Explore
_
Co-Authors (73)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_